MX9307644A - Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo. - Google Patents

Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.

Info

Publication number
MX9307644A
MX9307644A MX9307644A MX9307644A MX9307644A MX 9307644 A MX9307644 A MX 9307644A MX 9307644 A MX9307644 A MX 9307644A MX 9307644 A MX9307644 A MX 9307644A MX 9307644 A MX9307644 A MX 9307644A
Authority
MX
Mexico
Prior art keywords
amino
tetrahidrobenzotiazole
propil
medication including
antidepressive effect
Prior art date
Application number
MX9307644A
Other languages
English (en)
Inventor
Franco Borsini
Rudolf Hammer
Joachim Mierau
Erich Lehr
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of MX9307644A publication Critical patent/MX9307644A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

El invento se refiere a la utilización de pramipexol y como medicamento con efecto antidepresivo que lo contiene.
MX9307644A 1992-12-05 1993-12-03 Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo. MX9307644A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung

Publications (1)

Publication Number Publication Date
MX9307644A true MX9307644A (es) 1994-06-30

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307644A MX9307644A (es) 1992-12-05 1993-12-03 Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.

Country Status (29)

Country Link
US (1) US6191153B1 (es)
EP (1) EP0675717B1 (es)
JP (1) JP3221880B2 (es)
KR (1) KR100311165B1 (es)
CN (1) CN1052400C (es)
AT (1) ATE183091T1 (es)
AU (1) AU674378B2 (es)
BG (1) BG62475B1 (es)
CA (1) CA2150131C (es)
CZ (1) CZ282679B6 (es)
DE (2) DE4241013A1 (es)
DK (1) DK0675717T3 (es)
ES (1) ES2136725T3 (es)
FI (1) FI952734A (es)
GR (1) GR3031521T3 (es)
HK (1) HK1019003A1 (es)
HU (1) HU221014B1 (es)
IL (1) IL107870A (es)
MX (1) MX9307644A (es)
NO (1) NO306930B1 (es)
NZ (1) NZ258876A (es)
PL (1) PL309282A1 (es)
RU (1) RU2157685C2 (es)
SG (1) SG49228A1 (es)
SK (1) SK281441B6 (es)
TW (1) TW362973B (es)
UA (1) UA35604C2 (es)
WO (1) WO1994013287A1 (es)
ZA (1) ZA939065B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
CA2415815A1 (en) * 2000-07-06 2002-01-17 Nigel H. Greig Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
PA8578501A1 (es) * 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
DE102004006808A1 (de) 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
RS52057B2 (sr) * 2004-08-13 2018-03-30 Boehringer Ingelheim Int Formulacija tablete sa produženim oslobađanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
AU2005271193B2 (en) * 2004-08-13 2011-11-24 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
BRPI0607684A2 (pt) * 2005-04-04 2009-09-22 Takeda Pharmaceutical composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
CA2626249A1 (en) * 2005-10-18 2007-04-26 Boehringer Ingelheim International Gmbh Use of pramipexol for treating moderate to severe restless legs syndrome (rls)
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
EP1988875A2 (en) * 2006-02-10 2008-11-12 Boehringer Ingelheim International GmbH Modified release formulation
CN110730662A (zh) * 2017-04-10 2020-01-24 才思治疗公司 用于治疗共核蛋白病的nk1-拮抗剂组合和方法
CN111032158A (zh) * 2017-06-30 2020-04-17 才思治疗公司 用于治疗抑郁的nk-1拮抗剂组合物和方法
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186087B1 (de) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
IL107870A (en) 1996-12-05
AU5715294A (en) 1994-07-04
AU674378B2 (en) 1996-12-19
SG49228A1 (en) 1998-05-18
WO1994013287A1 (de) 1994-06-23
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11
HK1019003A1 (en) 2000-01-14
DE4241013A1 (de) 1994-06-09
SK281441B6 (sk) 2001-03-12
SK74095A3 (en) 1996-05-08
TW362973B (en) 1999-07-01
NO952207D0 (no) 1995-06-02
NO306930B1 (no) 2000-01-17
ZA939065B (en) 1994-08-04
FI952734A0 (fi) 1995-06-05
HU9501623D0 (en) 1995-08-28
CA2150131C (en) 2004-09-21
BG62475B1 (bg) 1999-12-30
FI952734A (fi) 1995-06-05
RU2157685C2 (ru) 2000-10-20
HU221014B1 (hu) 2002-07-29
GR3031521T3 (en) 2000-01-31
HUT71798A (en) 1996-02-28
ATE183091T1 (de) 1999-08-15
PL309282A1 (en) 1995-10-02
BG99700A (bg) 1996-04-30
KR950703953A (ko) 1995-11-17
UA35604C2 (uk) 2001-04-16
NO952207L (no) 1995-06-02
CN1052400C (zh) 2000-05-17
JPH08504201A (ja) 1996-05-07
IL107870A0 (en) 1994-04-12
NZ258876A (en) 1997-07-27
EP0675717A1 (de) 1995-10-11
DK0675717T3 (da) 2000-02-28
CZ144095A3 (en) 1996-03-13
DE59309733D1 (de) 1999-09-16
US6191153B1 (en) 2001-02-20
KR100311165B1 (ko) 2001-12-28
JP3221880B2 (ja) 2001-10-22
CN1091635A (zh) 1994-09-07
ES2136725T3 (es) 1999-12-01
CA2150131A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
ES2173858T3 (es) Analogos de huperzina a.
BE883069A (fr) Derives de phenylethylamine, leur preparation et utilisation ainsi que composition contenant ces derives.
ES2100263T3 (es) Nuevas isohirudinas sinteticas con estabilidad mejorada.
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
PT1000067E (pt) Tiazolobenzo-heterociclos sua preparacao e medicamentos que os contem
CL2004000486A1 (es) Compuestos de (piridinil amino)-bencisoxazol y bencisotiazol substituidos, la composicion farmaceutica que los contiene, su procedimiento de preparacion a partir de un bencisoxazol o bencisotiazol y su uso como farmaco con actividad antidepresiva.
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
ES2122005T3 (es) Medicamento que contiene (-)-metrifonato.
IL85560A0 (en) Pharmaceutical compositions containing an antidepressant and a synergist
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
SE9303855D0 (sv) The use of ester of inositoltrisphosphate for the preparing of an analgetic medicamnet
IT8020075A0 (it) Composto ad attivita'psicostimolante e antidepressiva, processo per la sua preparazione e composizioni farmaceutiche relative.
ES2103218B1 (es) Derivados de piridona azetidinil substituidos con actividad antimicrobiana.
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
FR2390421A1 (fr) 1-acyl-2-hydroxy-1,3-diaminopropanes a titre de nouveaux medicaments
KR960021044A (ko) 세코노가노사이드를 포함하는 b형 간염 치료제
IT8919283A0 (it) Composizione farmaceutica comprendente come ingrediente attivo 3 n piperidinometil azino metilrifamicina s.
MX9303606A (es) Derivados de azabicicloheptano n-sustituidos, su obtencion y uso.
UA31266A (uk) Лікувальний засіб "дінальгін"
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.